Celldex Therapeutics Stock Forecast - Price Action Indicator
| CLDX Stock | USD 26.85 0.68 2.60% |
Celldex Stock Forecast is based on your current time horizon.
At this time, The RSI of Celldex Therapeutics' share price is at 50 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Celldex Therapeutics, making its price go up or down. Momentum 50
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.93) | EPS Estimate Current Year (3.59) | EPS Estimate Next Year (4.42) | Wall Street Target Price 53.3571 | EPS Estimate Current Quarter (0.89) |
Using Celldex Therapeutics hype-based prediction, you can estimate the value of Celldex Therapeutics from the perspective of Celldex Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Celldex Therapeutics using Celldex Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Celldex using crowd psychology based on the activity and movement of Celldex Therapeutics' stock price.
Celldex Therapeutics Short Interest
An investor who is long Celldex Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Celldex Therapeutics and may potentially protect profits, hedge Celldex Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 23.3303 | Short Percent 0.1466 | Short Ratio 10.59 | Shares Short Prior Month 6.9 M | 50 Day MA 26.352 |
Celldex Therapeutics Hype to Price Pattern
Investor biases related to Celldex Therapeutics' public news can be used to forecast risks associated with an investment in Celldex. The trend in average sentiment can be used to explain how an investor holding Celldex can time the market purely based on public headlines and social activities around Celldex Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Celldex Therapeutics Implied Volatility | 0.83 |
Celldex Therapeutics' implied volatility exposes the market's sentiment of Celldex Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Celldex Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Celldex Therapeutics stock will not fluctuate a lot when Celldex Therapeutics' options are near their expiration.
Celldex Therapeutics after-hype prediction price | USD 26.85 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Celldex Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Celldex contract
Based on the Rule 16, the options market is currently suggesting that Celldex Therapeutics will have an average daily up or down price movement of about 0.0519% per day over the life of the 2026-03-20 option contract. With Celldex Therapeutics trading at USD 26.85, that is roughly USD 0.0139 . If you think that the market is fully incorporating Celldex Therapeutics' daily price movement you should consider acquiring Celldex Therapeutics options at the current volatility level of 0.83%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Celldex Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Celldex Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Celldex Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Celldex Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Celldex Therapeutics' open interest, investors have to compare it to Celldex Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Celldex Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Celldex. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Celldex Therapeutics Additional Predictive Modules
Most predictive techniques to examine Celldex price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Celldex using various technical indicators. When you analyze Celldex charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Celldex Therapeutics Volatility | Backtest Celldex Therapeutics | Information Ratio |
Celldex Therapeutics Trading Date Momentum
| On January 22 2026 Celldex Therapeutics was traded for 26.85 at the closing time. The top price for the day was 26.96 and the lowest listed price was 25.70 . The trading volume for the day was 308.6 K. The trading history from January 22, 2026 did not affect price variability. The overall trading delta against the current closing price is 3.05% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Celldex Therapeutics to competition |
Other Forecasting Options for Celldex Therapeutics
For every potential investor in Celldex, whether a beginner or expert, Celldex Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Celldex Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Celldex. Basic forecasting techniques help filter out the noise by identifying Celldex Therapeutics' price trends.Celldex Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Celldex Therapeutics stock to make a market-neutral strategy. Peer analysis of Celldex Therapeutics could also be used in its relative valuation, which is a method of valuing Celldex Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Celldex Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Celldex Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Celldex Therapeutics shares will generate the highest return on investment. By undertsting and applying Celldex Therapeutics stock market strength indicators, traders can identify Celldex Therapeutics entry and exit signals to maximize returns.
Celldex Therapeutics Risk Indicators
The analysis of Celldex Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Celldex Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting celldex stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.44 | |||
| Semi Deviation | 2.91 | |||
| Standard Deviation | 3.15 | |||
| Variance | 9.91 | |||
| Downside Variance | 9.08 | |||
| Semi Variance | 8.49 | |||
| Expected Short fall | (2.56) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Celldex Therapeutics
The number of cover stories for Celldex Therapeutics depends on current market conditions and Celldex Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Celldex Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Celldex Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Celldex Therapeutics Short Properties
Celldex Therapeutics' future price predictability will typically decrease when Celldex Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Celldex Therapeutics often depends not only on the future outlook of the potential Celldex Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Celldex Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 64.4 M | |
| Cash And Short Term Investments | 725.3 M |
Additional Tools for Celldex Stock Analysis
When running Celldex Therapeutics' price analysis, check to measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.